Market Research Logo

Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Ono Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ono Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note:*:Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Ono Pharmaceutical Co., Ltd.
  • The report provides overview of Ono Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Ono Pharmaceutical Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Ono Pharmaceutical Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Ono Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Ono Pharmaceutical Co., Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Ono Pharmaceutical Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Ono Pharmaceutical Co., Ltd. Snapshot
Ono Pharmaceutical Co., Ltd. Overview
Key Facts
Ono Pharmaceutical Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Ono Pharmaceutical Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Ono Pharmaceutical Co., Ltd. - Pipeline Products Glance
Ono Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Ono Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Ono Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Ono Pharmaceutical Co., Ltd. - Drug Profiles
(carbidopa + levodopa prodrug) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
abatacept - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
anamorelin hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
E-0001163 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
etelcalcetide hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ivabradine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
landiolol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
metyrosine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody for Autoimmune Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nivolumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-2952 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-4059 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-4127 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-4232 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-4310321 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-4474 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-7268MX1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-7268MX2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-8055 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-8430506 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ONO-8577 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
opicapone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
oprozomib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
salirasib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Antagonize S1P2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit Protease Enzyme for Undisclosed Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize Lysophosphatidic Acid Receptor 1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Ono Pharmaceutical Co., Ltd. - Pipeline Analysis
Ono Pharmaceutical Co., Ltd. - Pipeline Products by Target
Ono Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
Ono Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
Ono Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
Ono Pharmaceutical Co., Ltd. - Dormant Projects
Ono Pharmaceutical Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
arundic acid
asimadoline
ceralifimod
freselestat
gemilukast
ipilimumab
limaprost
methylnaltrexone bromide
NIP-022
ONO-1266
ONO-2506-PO
ONO-4053
ONO-4127
ONO-5129
ONO-5334
ONO-6126
ONO-8539
remimazolam
rivenprost
tecemotide
Ono Pharmaceutical Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Ono Pharmaceutical Co., Ltd., Key Facts
Ono Pharmaceutical Co., Ltd. - Pipeline by Indication, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016
Ono Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016
Ono Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016
Ono Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2016
Ono Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
Ono Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2016
Ono Pharmaceutical Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Ono Pharmaceutical Co., Ltd. - Pre-Registration, 2016
Ono Pharmaceutical Co., Ltd. - Phase III, 2016
Ono Pharmaceutical Co., Ltd. - Phase II, 2016
Ono Pharmaceutical Co., Ltd. - Phase I, 2016
Ono Pharmaceutical Co., Ltd. - Preclinical, 2016
Ono Pharmaceutical Co., Ltd. - Discovery, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Target, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
Ono Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2016
Ono Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2016
Ono Pharmaceutical Co., Ltd., Other Locations
Ono Pharmaceutical Co., Ltd., Subsidiaries
List of Figures
Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016
Ono Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016
Ono Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016
Ono Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report